Phase 1/2 Dose-Escalation/Dose-Expansion Study of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma (T-ALL/LBL)

Authors:
  • AGArmin Ghobadi
    Armin Ghobadi
  • IAIbrahim Aldoss
    Ibrahim Aldoss
  • SMShannon L. Maude
    Shannon L. Maude
  • DBDeepa Bhojwani
    Deepa Bhojwani
  • AWAlan S. Wayne
    Alan S. Wayne
  • ABAshish Bajel
    Ashish Bajel
  • DBDholaria Bhagirathbhai
    Dholaria Bhagirathbhai
  • RFRawan G Faramand
    Rawan G Faramand
  • RMRyan J. Mattison
    Ryan J. Mattison
  • MRMichael P. Rettig
    Michael P. Rettig
  • KJKenneth Jacobs
    Kenneth Jacobs
  • OBOuiam Bakkacha
    Ouiam Bakkacha

Abstract
No abstract available